Injectable Platelets Rich Fibrin Versus Hyaluronic Acid for Alveolar Ridge Preservation
Alveolar Ridge Enlargement
About this trial
This is an interventional treatment trial for Alveolar Ridge Enlargement
Eligibility Criteria
Inclusion Criteria: non-restorable tooth located in anterior maxillary arch (upper right second premolar to upper left second premolar) socket type I according to Elian et al., 2007 classification tooth to be extracted was free from acute periapical infection or sinus tracts thick gingival biotype Systemically free according to modified Cornell medical index Exclusion Criteria: smokers patients bruxism habits patients with poor oral hygiene or not willing to perform oral hygiene measures
Sites / Locations
- Doaa Adel Salah Khattab
- Doaa Khattab
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Active Comparator
Injectable platelets rich fibrin
Hyaluronic acid
Xenograft
Injectable platelets rich fibrin was prepared where 10 ml of patient venous blood was centrifuged without anti-coagulants (plain plastic glass-coated) at 700 rpm speed for only 3 minutes, xenograft was mixed with I-PRF to make sticky bone, sticky bone was placed into extraction socket till the socket was fully filled up to the gingival margin
Hyaluronic acid (HA) syringe containing 1 mL of cross-linked hyaluronic at a concentration of 20 mg/ml in a saline phosphate buffer solution at sterilized content was used. HA was mixed with particulate xenograft 1:10 ratio to form a putty consistency for condensation and was placed into extraction socket till the socket was fully filled up to the gingival margin
Xenograft was mixed with saline, placed in extraction socket till the socket is fully filled up to the gingival margin